Results 21 to 30 of about 57,278 (332)
Increased rate of any retinopathy risk in patients with masked hypertension
Clinical and Experimental Hypertension, 2020 Purpose Hypertension is a common chronic disorder with end organ damage. Hypertensive retinopathy is a response to elevated blood pressure characterized retinal arteriolar intimal thickening, hyperplasia of the intima-media end with sclerosis. There is a
Timuçin Yıldırım +3 more
doaj +1 more source
Evaluation of atrial electromechanical properties in patients with masked hypertension
Clinical and Experimental Hypertension, 2020 Purpose In this study, we evaluated the electromechanical properties of atriums in patients with masked hypertension by using tissue Doppler echocardiographic technique to predict the predisposition to atrial arrhythmias.
Selçuk Özkan +2 more
doaj +1 more source
Masked Hypertension: Fragile in More Ways Than One. [PDF]
Hypertension, 2020 Cohen JB.
europepmc +4 more sources
The Journal of Clinical Hypertension, 2021 In the ANAFIE Registry home blood pressure subcohort, we evaluated 5204 patients aged ≥75 years with non‐valvular atrial fibrillation (NVAF) to assess blood pressure (BP) control, prevalence of masked hypertension, and anticoagulant use.
Kazuomi Kario +18 more
doaj +1 more source
Is Masked Hypertension an underlying Cause of Unexplained Left Ventricle Hypertrophy?
Clinical and Experimental Hypertension, 2021 Objectives Unexplained left ventricular hypertrophy (ULVH) is defined as increased wall thickness in the absence of conditions that predispose to hypertrophy.
Ö. Çağlar Yılmaz, Selçuk Özkan
doaj +1 more source
Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: A population-based study of older individuals in Spain [PDF]
, 2017 Blood pressure (BP) variability and nocturnal decline in blood pressure are associated with cardiovascular outcomes. However, little is known about whether these indexes are associated with white-coat and masked hypertension.
Banegas, José Ramón +6 more
core +2 more sources
Total methylated arginine load as a risk parameter in subjects with masked hypertension
Clinical and Experimental Hypertension, 2020 Asymmetric dimethylarginine, symmetric dimethylarginine, and L-monomethylarginine are originated from the subsequent proteolytic catalysis of methylated arginine residues on different proteins and inhibit the endogenous nitric oxide generation.
Muserref Hosaf +6 more
doaj +1 more source
Masked Hypertension in Treated Hypertensive Patients [PDF]
American Journal of Hypertension, 2006 We read with interest the Critique article by Clement regarding our article and we are grateful for his comments. However, some aspects need to be clarified to avoid confusion. Clement states that the population we studied may be different from that seen in regular hypertension clinics, and that we come up with a very high prevalence of masked ...
PIERDOMENICO, Sante Donato +2 more
openaire +3 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundStudies consisting mostly of whites have shown that the prevalence of masked hypertension differs by prehypertension status. Using data from the Jackson Heart Study, an exclusively African American population‐based cohort, we evaluated the ...
Nicole Redmond +7 more
doaj +1 more source
Medicine Science, 2023 Fetal growth restriction (FGR) is a major risk factor for complicated pregnancy including stillbirth. The all-pathophysiology results in uteroplacental insufficiency. Hypertension chronic or pregnancy-related complicates the all-prenatal periods.
Nazli Topfedaisi Ozkan +3 more
doaj +1 more source